Medication info
Aida Tablet 5 mg (Dapagliflozin Propanediol Hydrate)

Aida Tablet 5 mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›6.15mg / 1 tablet
Manufacturer / importer
Ankuk Pharmaceutical Co., Ltd.
Appearance
Yellow, bilaterally convex, round film-coated tablets
Packaging
28 tablets/box [7 tablets/PTP X 4]
Approval status
Active

MFDS item code 202204325 · Approved 2022.12.02 · Insurance code 650205930

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for both monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablets should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Ankuk Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • poor blood glucose control
  • cardiovascular disease
  • cardiovascular risk factors
View approved original text

This medication is used as an adjunct to diet and exercise to help control blood glucose in patients with type 2 diabetes. It can be administered alone or in combination with other medications. In addition, it is important to refer to clinical trial information guided by experts regarding the use of this medication in patients whose blood glucose is not adequately controlled and who have or are at risk for cardiovascular disease. Overall, this drug is used to improve patient health through effective management of blood glucose in type 2 diabetes.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for both monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablets should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be used in patients with a history of allergic reactions, individuals with type 1 diabetes, and certain genetically lactose-intolerant patients. Additionally, it is advisable not to administer this medication to patients undergoing dialysis. Caution should be exercised in administering this medication to patients with reduced fluid volume or impaired kidney function, and fluid status and kidney function should be carefully evaluated before administration. This medication may lower blood pressure, and special attention is needed in older adults or patients on diuretics, as the risk of hypotension is higher. Serious metabolic disorders such as diabetic ketoacidosis may occur, so signs should be monitored, and testing should be done immediately if suspected. The risk of genital and urinary infections may increase, so treatment should be sought promptly if symptoms of infection arise. When used in combination with insulin or sulfonylureas, dosage adjustments may be necessary to reduce the risk of hypoglycemia. It is recommended that pregnant or breastfeeding women do not use this medication. The safety and effectiveness in children have not been established, so use is not recommended. In case of overdose, there is no specific antidote, so appropriate treatment should be given based on symptoms, and greater caution is needed if there are issues with kidney function. Regular check-ups and tests with healthcare professionals are vital to reduce the risks of fluid volume depletion, hypotension, infection, and ketoacidosis. Moreover, while this medication does not significantly impair driving or operating machinery, caution should be exercised for symptoms of hypoglycemia when taken with other hypoglycemic agents. Finally, store it out of reach of children and keep it in the original container to maintain quality.

Side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, renal tubulointerstitial nephritis, vulvar pruritus, genital pruritus, elevated hematocrit, initial treatment renal creatinine clearance reduction, dyslipidemia, initial treatment elevated blood creatinine, increased blood urea nitrogen, weight loss, acute pyelonephritis, rash, angioedema, myasthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, chest pain, sensory disturbances, cerebral infarction, nerve compression, sensory loss, drowsiness, tension-type headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremor, herpes simplex, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, influenza-like symptoms, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, irregular menstruation, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcer, excessive sweating eczema, nummular eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, dry eye, ocular pain, retinal disorders, visual impairment, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid edema, keratitis, ocular hypertension, visual impairment, vitreous floaters, oropharyngeal pain, allergic rhinitis, asthma, voice disorders, epistaxis, sleep apnea syndrome, wheezing, atherosclerosis, flushing, peripheral coldness, varicose veins, vascular headaches, orthostatic hypotension, atrial fibrillation, diastolic dysfunction, palpitations, anxiety disorders, auditory hallucinations, insomnia, fatty liver, gallbladder polyp, tinnitus, anal genital warts, adenoma, neuroma, pituitary neoplasm of unspecified type, male reproductive gland hypofunction, thyroid cyst, thyroid nodule, food allergy, polycythemia, dyspepsia, nausea, diarrhea, vomiting, urinary retention, elevated alanine aminotransferase, elevated aspartate aminotransferase, decreased appetite, hyperosmia, headache, nasopharyngitis, upper respiratory infection, chest discomfort, hunger, vaginal discharge, pruritus, arthralgia, palpitations

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to prevent exposure to air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius, at room temperature.

Appearance and packaging

Appearance

Yellow, bilaterally convex, round film-coated tablets

Package unit

28 tablets/box [7 tablets/PTP X 4]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.